Hepatic steatosis - satellite ibu

Enweghị nchịkwa imeju ọnọdụ mere site metabolic ọrịa na oriri na-edozi, nke e nwere bụ onye na ìgwè abụba inclusions, nakwa dị ka abụba ụmụ irighiri mmiri na hepatocytes nke imeju steatosis a na-akpọ ma ọ bụ "imeju abụba". Hepatic steatosis ( «steatosis hepatis», Greek.) Ka abụ a iche iche ọrịa, na nwere uma nke syndrome. Ọ bụrụ na ihe karịrị 5% nke imeju arọ bụ abụba, ọ na-akpọ abụba.

The pathogenesis nke ọrịa a na a na-amụ. Isi ihe mere akpata ya omume, ọ na-chere: oké oriri nke free ọdụdụ asịd, mụbara njikọ na esterification nke ọdụdụ asịd, belata ha ọxịdashọn na-ebelata protein njikọ na secretion nke lipoproteins mebiri.

Isi etiological ihe na-agụnye: imeju toxicity, endocrine na metabolic ọrịa, ekwukwa n'akwụkwọ ahaghị nhata na hypoxia. A pụrụ iche n'etiti ndị na-egbu egbu ọdịdị nke ihe ọ bụ nke na-emebi àgwà na ekwukwa n'akwụkwọ ahaghị nhata, ọrụ nke ndị ọzọ na-egbu egbu ihe na-erughị ihe dị mkpa. Ogo degenerative mgbanwe na-agba nke na ya mmepe, na elu na ibu ego nke mmanya gwusia. Mgbe ụfọdụ na-amalite ịṅụ ọgwụ hepatic steatosis, dị ka ọgwụ nje ọgwụgwọ, tuberkulostaticheskoy ọgwụ ọjọọ, corticosteroids na cytotoxic ọgwụ ọjọọ. The isi endocrine-metabolic ọrịa na-agụnye ọrịa shuga, thyroid ọrịa, Cushing si syndrome na mkpokọta ibu oké ibu.

Hepatic steatosis: mgbaàmà.

E nwere ihe abụọ bụ isi ụdị nke morphological ịrịba ama nke oké ìgwè abụba ke imeju: microscopic na macroscopic ìgwè. Globular ma ọ bụ macroscopic ìgwè e ji mara maka aṅụrụma, ibu oké ibu, na nke abụọ ụdị ọrịa shuga. Osisi ike steatosis ụdị kwekọrọ na-abawanye na ngụkọta arọ ahụ, ma, mgbe ọ na-kpukpru usen (agụụ ma ọ bụ ala kalori nri) nke a index nwekwara mbelata, na imeju na ọrụ laghachi nkịtị.

N'ezie nke ọrịa na-abụkarị ogologo oge, ogologo oge, oge ikwu ngbaghara dochie exacerbations oge, nke na-emekarị triggered site anụ ahụ ma ọ bụ iche echiche overexertion, na-efe efe, na mmanya oriri. Ọtụtụ mgbe, ọrịa bụ asymptomatic, ma ụfọdụ ọrịa na-eche arọ na ejupụta na nri elu quadrant, n'ime eriri ma ọ bụ epigastric n'ógbè afo, bloating na ekweghị ibe nọrọ na abụba oriri. Kasị susceptible ka imeju steatosis inyom na ụba ahu aro. Diagnosis nke ọrịa a rụrụ site ultrasound, magnetik resonance na agbakọrọ tomography. Ọzọkwa emepụta Biochemical ọbara ule, ndị ikpeazụ nchoputa na-guzosie ike mgbe a agịga biopsy nke imeju.

Steatosis imeju: ọgwụgwọ.

Ọrịa chọpụtara na hepatic steatosis kenyere a na nlezianya nri nke ebukarịghị edozi na abụba na-ejedebeghị. Ọzọkwa prescribers nyere aka melite abụba metabolism (folic acid, vitamin B12, choline chloride, lipoic acid). Ọzọkwa kenyere n'ikuku imeju preparations ndị dị otú ahụ dị ka ripazon, na progepar Syrepar na zuru ezu emega ahụ.

Prevention of hepatic steatosis.

Ọtụtụ mgbe ọrịa na-adị mgbe oké ojiji nke anụmanụ abụba, nakwa dị ka mebiri nke protein metabolism, ya mere, ihe dị mkpa ọtụtụ nke mgbochi nke hepatic steatosis bụ a kwesịrị isi nri. Ọzọkwa, iji steatosis mgbochi nwere ike ikwu supplementation nke antioxidants, na Mmeju nwere detoxifying Njirimara. E wezụga na ọ dị mkpa iji zere ogologo oge digestive ọrịa, na, na-enweghị na-eche na omume nke nsogbu, competently na-adọ na-emeso ha.